Industry calls for seat at reorganised GHTF table
This article was originally published in Clinica
The group of medtech trade associations that participated in the Global Harmonization Task Force from its beginning strongly believe that industry can continue to provide valuable input to the forum and that it should have a seat at the table, Ralph Ives executive vice-president of Global Strategy and Analysis at the US medtech industry association, AdvaMed, an active player at the Global Medical Technology Alliance (GMTA), told Clinica.
You may also be interested in...
Erik Hansson remains deputy head of devices in a move to the European Commission’s DG Sante from DG Grow. He now answers to a newly appointed devices head who shares a common educational background but whose recent pharmaceutical role may unsettle the devices industry.
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
It seems to be game over for anyone who might have been hoping the European Commission would do a U-turn on its decision to use the Italian CND nomenclature as the basis for communication in Eudamed, instead of the well-established GMDN. But GMDN is strong in its resolve to remain a vital global nomenclature service.